Cardiologist Weighs In on Negative Vytorin Study

This week, the makers of the drug Vytorin released a long-awaited study that raises questions about whether the drug has an impact in reducing the incidence of heart attacks and strokes.

Dr. Stuart Seides, associate director of cardiology at the Washington Hospital Center, has prescribed the drug to his patients selectively and says he will continue to do so despite the study.

Seides talks with Melissa Block.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.